H|T: The Healthtech Times – OMERS reportedly puts LifeLabs up for sale
Plus: PointClickCare’s acquisition spree continues with US healthtech company.
Healthtech
Femtech Canada officially launches network to support women’s health innovation
Network includes over 120 companies, industry partners, investors, accelerators.
CBIV surpasses $135 million CAD in final close to back women, children-focused healthtech startups
With Fund I, Toronto’s CBIV targets both market returns and impact.
TIAP partners with OBIO to open applications for healthtech funding stream
Selected companies will receive up to $200,000 in grant, dilutive funding.
H|T: The Healthtech Times – This DeepMind spin-off wants to cut drug discovery times in half
Plus: Clinia secures $10 million and partnership with Telus Health.
PointClickCare continues growth through acquisition with American HealthTech purchase
American HealthTech was divested by previous owner CPSI.
1QBit spinout Good Chemistry acquired by SandboxAQ
Good Chemistry’s CEO and team will join SandboxAQ’s simulation teams.
H|T: The Healthtech times – Custom Health to go public via SPAC at $185 million valuation
Plus: 23andMe says maybe you should’ve changed your password.
Clinia secures Series A funding, partnership with Telus Health to deploy its search tech
CEO says endorsement from Canada’s largest healthtech player gives Clinia “visa” it needs to catch big US fish.
BenchSci trims headcount citing generative AI, economic conditions
BenchSci confirmed to BetaKit that it laid off 17 percent of its workforce.
Social Finance Fund-backed Realize Capital Partners reveals first nine investments
Recipients include Idealist, Maple Bridge, PaceZero, Raven, Relentless, and The51.
MedEssist’s Joella Almeida on going slow with AI in healthtech
AI’s accuracy problem could spell trouble for patients and practitioners.
H|T: The Healthtech Times – SmileDirectClub shuts down shortly after declaring bankruptcy
Plus: The silly things women’s health entrepreneurs hear from male VCs.
H|T: The Healthtech Times – Healthtech startups among targets of Sixty Degree Capital’s new $338-million CAD fund
Plus: Medtronic’s $738 million acquisition is cancelled.
Vistara Growth secures $200-million CAD initial close for fifth private credit fund
Vistara sees opportunity post-SVB as bank lenders, VCs pull back.